sacituzumab,Pembrolizumab,Avelumab,Zimberelimab,Domvanalimab
Gilead,Merck,Pfizer,Arcus Biosciences,Otsuka
['cohort 1', 'kn-361', 'pembro', ' sg ', 'trophy,u-01']
 : 1) phiii kn-361 of #1l pembro vs chemo/pembro #cr may be an early endpt (de-escalation strategies?) muc, 2) diff to associate pembro efficacy in variant histology #muc, 3) trophy-u-01 cohort 1 phii ugt1a1 homozygous (13%) w/num higher aes to sg #asco23 
Medical oncologist and researcher in gastrointestinal and genitourinary cancers @CedarsSinai. Hematology/Oncology fellowship @cityofhope